Hydrochloric Acid

Hydrochloric Acid

SCHEMBL45755

CCCCCOCC[N+](C)(C)CCOCCCCC.[Cl-]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 known ✓ P08172 1/20 0.42
CHRM1 known ✓ P11229 1/20 0.42
CHRM3 known ✓ P20309 1/20 0.42
SLC6A2 known ✓ P23975 1/20 0.42
SLC6A3 known ✓ Q01959 1/20 0.42
HTT P42858 4/20 0.50
DNM1 Q05193 7/20 0.48
PRKD3 O94806 1/20 0.47
PRKCG P05129 1/20 0.47
PRKCB P05771 1/20 0.47
PRKCA P17252 1/20 0.47
PRKCH P24723 1/20 0.47
PRKCI P41743 1/20 0.47
PRKCE Q02156 1/20 0.47
PRKCQ Q04759 1/20 0.47
PRKCZ Q05513 1/20 0.47
PRKCD Q05655 1/20 0.47
PRKD1 Q15139 1/20 0.47
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2912559 0.98 HTT (0.54) HTTDNM1PRKD3PRKCGPRKCB
SCHEMBL8040635 0.98 HTT (0.52) HTTDNM1PRKD3PRKCGPRKCB
SCHEMBL13701161 0.91 HTT (0.65) HTTDNM1PRKD3PRKCGPRKCB
Bromide SCHEMBL10492636 0.89 DNM1 (0.64) HTTDNM1PRKD3PRKCGPRKCB
Hydrochloric Acid SCHEMBL7940293 0.88 HTT (0.68) HTTDNM1KMT2AMLNRNR1I2
SCHEMBL9962965 0.87 HTT (0.60) HTTDNM1PRKD3PRKCGPRKCB
Hydrochloric Acid SCHEMBL2872033 0.87 LPAR1 (0.45) HTTPRKD3PRKCGPRKCBPRKCA
Hydrochloric Acid SCHEMBL2872041 0.87 LPAR1 (0.45) HTTPRKD3PRKCGPRKCBPRKCA
SCHEMBL13701162 0.86 HTT (0.65) HTTDNM1KMT2AMLNRNR1I2
Hydrochloric Acid SCHEMBL253903 0.86 PRKD3 (0.61) HTTDNM1PRKD3PRKCGPRKCB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 400 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240052276-A9 FLEXIBLE, POROUS, DISSOLVABLE SOLID SHEET ARTICLES CONTAINING CATIONIC SURFACTANT THE PROCTER AND GAMBLE COMPANY 2024-02-15 US claimed
US-20110281785-A1 FABRIC ENHANCERS COMPRISING NANO-SIZED LAMELLAR VESICLE GIZAW YONAS (US) 2011-11-17 US claimed
US-7928055-B2 Clear and/or translucent fabric enhancers comprising nano-sized particles THE PROCTER & GAMBLE COMPANY (US) 2011-04-19 US claimed
EP-2049640-A2 CLEAR AND/OR TRANSLUCENT FABRIC ENHANCERS COMPRISING NANO-SIZED PARTICLES The Procter and Gamble Company (US) 2009-04-22 EP claimed
EP-2049639-A1 FABRIC ENHANCERS COMPRISING NANO-SIZED LAMELLAR VESICLE The Procter and Gamble Company (US) 2009-04-22 EP claimed
US-20090042767-A1 Clear and/or translucent fabric enhancers comprising nano-sized particles THE PROCTER & GAMBLE COMPANY 2009-02-12 US claimed
US-20090042765-A1 Fabric enhancers comprising nano-sized lamellar vesicle PROCTER & GAMBLE COMPANY, THE 2009-02-12 US claimed
US-20080263780-A1 Fabric enhancing compositions comprising nano-sized particles and anionic detergent carry over tollerance THE PROCTER & GAMBLE COMPANY 2008-10-30 US claimed
WO-2008021893-A1 FABRIC ENHANCING COMPOSITIONS COMPRISING NANO-SIZED PARTICLES AND ANIONIC DETERGENT CARRY OVER TOLLERANCE THE PROCTER & GAMBLE COMPANY (US) 2008-02-21 WO claimed
WO-2008021895-A2 CLEAR AND/OR TRANSLUCENT FABRIC ENHANCERS COMPRISING NANO-SIZED PARTICLES THE PROCTER & GAMBLE COMPANY (US) 2008-02-21 WO claimed
WO-2008021892-A1 FABRIC ENHANCERS COMPRISING NANO-SIZED LAMELLAR VESICLE THE PROCTER & GAMBLE COMPANY (US) 2008-02-21 WO claimed
EP-4399269-A1 PHENOLIC COMPOSITIONS FOR MALODOR REDUCTION Milliken & Company (US) 2024-07-17 EP disclosed
US-12031113-B2 Composition comprising hueing agent MILLIKEN & COMPANY (US) 2024-07-09 US disclosed
US-12018232-B2 Multilayer dissolvable solid article containing solid particles for making the same THE PROCTER & GAMBLE COMPANY (US) 2024-06-25 US disclosed
US-20240197579-A9 MULTILAYER DISSOLVABLE SOLID ARTICLE CONTAINING COATING COMPOSITION AND PROCESS FOR MAKING THE SAME THE PROCTER AND GAMBLE COMPANY 2024-06-20 US disclosed
WO-1998003619-A1 CONCENTRATED FABRIC SOFTENING COMPOSITION AND HIGHLY UNSATURATED FABRIC SOFTENER COMPOUND THEREFOR THE PROCTER & GAMBLE COMPANY (US) 1998-01-29 WO disclosed
WO-1998002513-A1 SUBSTANTIALLY ODOR-FREE POLYHYDROXYL SOLVENTS THE PROCTER & GAMBLE COMPANY (US) 1998-01-22 WO disclosed
WO-1997034975-A1 CONCENTRATED FABRIC SOFTENING COMPOSITION WITH GOOD FREEZE/THAW RECOVERY AND HIGHLY UNSATURATED FABRIC SOFTENER COMPOUND THEREFOR THE PROCTER & GAMBLE COMPANY (US) 1997-09-25 WO disclosed
WO-1997034976-A1 CONCENTRATED, STABLE, PREMIX FOR FORMING FABRIC SOFTENING COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 1997-09-25 WO disclosed
WO-1997003170-A1 CONCENTRATED, WATER DISPERSIBLE, STABLE, FABRIC SOFTENING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1997-01-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240197579-A9 MULTILAYER DISSOLVABLE SOLID ARTICLE CONTAINING COATING COMPOSITION AND PROCESS FOR MAKING THE SAME SEPTIN8, DSTN, SEPTIN2 CHRM2 3213/4885CHRM1 4354/4885CHRM3 4273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.